"The
Report Partnerships, Licensing, Investments and M&A Deals and
Trends for January 2016 in Pharmaceuticals provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
GlobalData's
Partnerships,
Licensing, Investments and M&A Deals and Trends for January 2016
in Pharmaceuticals report is an essential source of data and trend
analysis on partnerships, licensing, mergers and acquisitions (M&As)
and financings in the pharmaceuticals industry. The report provides
detailed information on partnership and licensing transactions, M&As,
equity/debt offerings, private equity, and venture financing
registered in the pharmaceuticals industry in January 2016. The
report portrays detailed comparative data on the number of deals and
their value in the last six months, subdivided by deal types, various
therapy areas, and geographies. Additionally, the report provides
information on the top financial advisory firms in the
pharmaceuticals industry.
Data
presented in this report is derived from GlobalDatas proprietary
in-house Pharmaceuticals eTrack deals database and primary and
secondary research.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- dentify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
1
Table of Contents 2
1.1
List of Tables 6
1.2
List of Figures 9
2
Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1
Pharmaceuticals & Healthcare, Global, Deal Analysis, January 2016
12
2.2
Pharmaceuticals & Healthcare, Global, Major Deals, January 2016
14
2.2.1
Shire to Acquire Baxalta for USD32 Billion 14
2.2.2
Abbott Labs to Acquire Alere 16
2.2.3
Nestle Health Science Enters into Licensing Agreement with Seres
Therapeutics 17
2.2.4
Nanjing Xinjiekou to Acquire 65% Stake in China Cord Blood from
Golden Meditech for USD883 Million 18
2.2.5
Sanofi Enters into Licensing Agreement with Warp Drive Bio 19
2.3
Pharmaceuticals & Healthcare, Global, by Type, Number of Deals,
January 2016 21
2.4
Pharmaceuticals & Healthcare, Global, by Type, Deal Values,
January 2016 22
3
Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 23
3.1
Pharmaceuticals & Healthcare, Global, M&A, January 2016 23
3.1.1
Top M&A Deals in January 2016 24
3.1.2
Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy
Area, August 2015 - January 2016 25
3.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals,
January 2016 27
3.2.1
Top Equity Offering Deals in January 2016 28
3.2.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals by
Therapy Area, August 2015 - January 2016 29
3.3
Pharmaceuticals & Healthcare, Global, Private Equity and Venture
Capital Deals, January 2016 31
3.3.1
Top PE/VC Deals in January 2016 32
3.3.2
Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area,
January 2016 33
3.3.3
Pharmaceuticals & Healthcare, Global, Venture Capital Deals by
Stage of Financing, January 2016 34
3.3.4
Pharmaceuticals & Healthcare, Global, Top Venture Financing
Firms, August 2015-January 2016 36
3.3.5
Pharmaceuticals & Healthcare, Global, Top VC Backed Companies,
August 2015-January 2016 37
4
Pharmaceuticals & Healthcare, Global, Partnership Deals, January
2016 38
4.1
Pharmaceuticals & Healthcare, Global, Partnership Deals, January
2016 38
4.2
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, August 2015 - January 2016 40
4.3
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Upfront and Milestone Payments and Deal Values (US$ m), January 2016
42
4.3.1
Pharmaceuticals & Healthcare, Global, Top Partnership Deals by
Payment Mode, January 2016 43
4.4
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, by Upfront and Milestone Payments and Deal Values (US$
m), August 2015 - January 2016 44
4.5
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Number Of Deals, August 2015 - January 2016 46
4.6
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Deal Values (US$ m), August 2015 - January 2016 47
4.7
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
by Upfront & Milestone Payments and Deal Values (US$ m), August
2015 - January 2016 49
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment